NCT05539560

Brief Summary

Aim: The aim is to investigate the effect of olfactory training with essential oils versus olfactory training with placebo-oils in patients with COVID-19 induced olfactory dysfunction Study design: The study is a placebo-controlled randomized clinical trial with an intervention group and a control group. The intervention group receive four essential oils with scents of orange, lavender, clove, and peppermint. Patients in the control group receive a fragrance kit, consisting of the same containers, but with fragrance-free oils added. Both groups are instructed to smell each of the four oils for 30 seconds in the morning and evening, over a three-month intervention period. Patients are given a diary in which to record their olfactory training. The nurse or medical student instructing the patients in the training and performing the smell and taste tests is blinded. Study population: Patients referred to the Unit for Sense of Taste and Smell in the Department of Otorhinolaryngology Head \& Neck and Audiology at Rigshospitalet. Inclusion criteria:

  • Impaired sense of taste and smell following COVID-19 \> 3 months
  • Hyposmia (16.25-30.5) or anosmia (\<16) assessed by Sniffin' Sticks Olfactory Test for Threshold, Discrimination and Identification (TDI) performed in the Unit for Sense of Taste and Smell with or without parosmia based on medical history
  • \> 18 years of age Exclusion criteria:
  • Cause of hyposmia, anosmia or parosmia other than COVID-19
  • Does not read or speak Danish
  • Lack of compliance to perform daily olfactory training Procedures: \- TDI-test: To assess patients' sense of smell, the TDI-test with Sniffin' Sticks is used, which is a validated tool with normative data. Questionnaires: \- 'Taste and Smell Tool for Evaluation' is used to investigate quality of life related to impaired sense of taste and smell.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
65

participants targeted

Target at P25-P50 for not_applicable covid19

Timeline
Completed

Started Jun 2022

Longer than P75 for not_applicable covid19

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 29, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

September 2, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

September 14, 2022

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2024

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

September 23, 2024

Status Verified

September 1, 2024

Enrollment Period

1.8 years

First QC Date

September 2, 2022

Last Update Submit

September 19, 2024

Conditions

Keywords

Olfactory trainingQuality of lifeOlfactory dysfunctionCovid-19Parosmia

Outcome Measures

Primary Outcomes (1)

  • Change in Extended Sniffin' Sticks Test score

    Change in TDI score measured by Burghart Extended Sniffin' Sticks Test (TDI test). The TDI test, consists of a threshold test, a discrimination test, and an identification test. The results of the three subtests makes a total TDI score, where the minimum score is 1 and the maximum score is 48. A score \>30 indicates normal olfactory function, a score between 15-30 indicates hyposmia and a score \<15 indicates anosmia in the form of severely impaired or complete loss of olfaction.

    3 months follow-up

Secondary Outcomes (1)

  • Change in Quality of Life

    3 months follow-up

Study Arms (2)

Intervention group

EXPERIMENTAL

Olfactory training twice a day with essential oils

Other: Olfactory training with essential oils

Control group

PLACEBO COMPARATOR

Olfactory training twice a day with fragrance-free oils

Other: Olfactory training with fragrance-free oils

Interventions

Olfactory training twice daily with essential oils from Urtegaarden Aps with scents of orange, lavender, clove and peppermint. The olfactory training is performed every morning and evening, by smelling each of the oils for 30 seconds.

Also known as: Urtegaarden ApS Essential Oils
Intervention group

Olfactory training twice daily with fragrance-free oils from Urtegaarden Aps in the same four containers as the intervention group. The olfactory training is performed every morning and evening, by smelling each of the oils for 30 seconds.

Also known as: Urtegaarden ApS Essential Oils (Fragrance-free custom made)
Control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Olfactory dysfunction caused by COVID-19
  • Hyposmia (16.25-30.5) or anosmia (\<16) with or without parosmia assessed by TDI test with Sniffin Sticks performed in the Unit for Sense of Taste and Smell
  • \> 18 years of age

You may not qualify if:

  • Cause of hyposmia, anosmia or parosmia other than COVID-19
  • Does not read or speak Danish
  • Lack of compliance to perform daily olfactory training

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Otorhinolaryngology, Head and Neck Surgery & Audiology, Copenhagen University Hospital

Copenhagen, 2100, Denmark

RECRUITING

Related Publications (1)

  • Mogensen DG, Aanaes K, Andersen IB, Jarden M, Backer V. Effect of Olfactory Training in COVID-19 Related Olfactory Dysfunction-A Placebo-Controlled Trial. Laryngoscope. 2025 Dec;135(12):4849-4857. doi: 10.1002/lary.32275. Epub 2025 May 15.

MeSH Terms

Conditions

COVID-19Olfaction Disorders

Interventions

Olfactory TrainingOils, Volatile

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

TherapeuticsOilsLipids

Study Officials

  • Vibeke G Backer, Professor

    Rigshospitalet, Denmark

    STUDY CHAIR

Central Study Contacts

Ditte G Gertz Mogensen, PhD-student

CONTACT

Vibeke Backer, Professor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
PhD-student

Study Record Dates

First Submitted

September 2, 2022

First Posted

September 14, 2022

Study Start

June 29, 2022

Primary Completion

April 30, 2024

Study Completion

September 30, 2025

Last Updated

September 23, 2024

Record last verified: 2024-09

Locations